Halozyme Therapeutics, Inc. (NASDAQ:HALO)

CAPS Rating: 2 out of 5

A biopharmaceutical company dedicated to the development and commercialization of recombinant human enzymes for the drug delivery, palliative care, oncology and infertility markets.

Recs

0
Player Avatar GBrnjic (79.67) Submitted: 3/2/2007 10:24:45 PM : Outperform Start Price: $8.00 HALO Score: +2.22

Will rule the medical world

Report this Post 1 Comment
Member Avatar Somnambulo (96.41) Submitted: 6/10/2007 10:05:10 PM
Recs: 0

With their totally awesome -51% roe and -930% om?

Featured Broker Partners


Advertisement